Astrazeneca Plc Adr Stock Investor Sentiment
| AZN Stock | USD 68.73 0.20 0.29% |
About 59% of AstraZeneca PLC's investor base is looking to short. The analysis of overall sentiment of trading AstraZeneca PLC ADR stock suggests that many investors are alarmed at this time. AstraZeneca PLC's investor sentiment overview provides quick insight into current market opportunities from investing in AstraZeneca PLC ADR. The current market sentiment, together with AstraZeneca PLC's historical and current headlines, can help investors time the market. In addition, many technical investors use AstraZeneca PLC ADR stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Panic Vs Confidence
41
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use AstraZeneca PLC's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward AstraZeneca PLC ADR.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
AstraZeneca PLC stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of AstraZeneca daily returns and investor perception about the current price of AstraZeneca PLC ADR as well as its diversification or hedging effects on your existing portfolios.
AstraZeneca Historical Sentiment
Although AstraZeneca PLC's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding AstraZeneca, such as negative comments on social media and news outlets, may cause fear in the market and push AstraZeneca PLC's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of AstraZeneca.
AstraZeneca |
AstraZeneca PLC ADR Historical Investor Sentiment
Investor biases related to AstraZeneca PLC's public news can be used to forecast risks associated with an investment in AstraZeneca. The trend in average sentiment can be used to explain how an investor holding AstraZeneca can time the market purely based on public headlines and social activities around AstraZeneca PLC ADR. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
AstraZeneca PLC's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for AstraZeneca PLC and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average AstraZeneca PLC news discussions. The higher the estimate score, the more favorable the investor's outlook on AstraZeneca PLC.
AstraZeneca PLC Maximum Pain Price across 2024-04-19 Option Contracts
AstraZeneca PLC's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of AstraZeneca PLC close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of AstraZeneca PLC's options.
Far too much social signal, news, headlines, and media speculation about AstraZeneca PLC that are available to investors today. That information is available publicly through AstraZeneca media outlets and privately through word of mouth or via AstraZeneca internal channels. However, regardless of the origin, that massive amount of AstraZeneca data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AstraZeneca PLC news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AstraZeneca PLC relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AstraZeneca PLC's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AstraZeneca PLC alpha.
AstraZeneca PLC Performance against NYSE Composite
Price Growth (%) |
| Timeline |
| AstraZeneca PLC dividend paid on 25th of March 2024 | 03/25/2024 |
1 | Astrazeneca Rises As Market Takes a Dip Key Facts | 03/26/2024 |
2 | AstraZenecas Enhertu granted approval for HER-2 positive tumor-agnostic indications | 04/05/2024 |
3 | AstraZeneca, Daiichi Sankyo Drug Enhertu Becomes First Tumor-Agnostic ADC Cancer Med | 04/08/2024 |
4 | Ultimovacs Invitation to Business Update on April 17, 2024 | 04/09/2024 |
5 | Eli Lillys and AstraZenecas Former Head of Research Dr. Jan Lundberg Invests in AlzeCure and is Proposed for Election to its Board | 04/10/2024 |
6 | Air-Stable Ruthenium Catalyst to Revolutionize Industrial Chemistry | 04/11/2024 |
7 | No link between GLP-1s and suicidal thoughts, EU regulator says | 04/12/2024 |
Check out AstraZeneca PLC Hype Analysis, AstraZeneca PLC Correlation and AstraZeneca PLC Performance. Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for AstraZeneca Stock analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is AstraZeneca PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.059 | Dividend Share 2.9 | Earnings Share 1.9 | Revenue Per Share 2.4547 | Quarterly Revenue Growth 0.073 |
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.